Drug Type CAR-T |
Synonyms SCAR02 |
Target |
Action modulators |
Mechanism BCMA modulators(B-cell maturation protein modulators), CD19 modulators(B-lymphocyte antigen CD19 modulators) |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Clinical | China | 09 Apr 2024 | |
Scleroderma, Systemic | Clinical | China | 09 Apr 2024 | |
Systemic Lupus Erythematosus | Clinical | China | 09 Apr 2024 |